Adia Nutrition Secures Lease for First Clinic in Winter Park, Florida

Rhea-AI Summary

Adia Nutrition has secured a lease for its first medical clinic at Winter Park Medical Center, Florida. The fully built-out and recently remodeled facility will feature a rare stem cell extraction department and private IV rooms, specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Multiple Sclerosis patients. The clinic is expected to be operational by year-end and begin accepting patients on January 1st, 2025. This strategic expansion represents the company's model for future nationwide clinic rollouts.

Positive

• Secured first physical clinic location with ready-to-use facilities, reducing setup time and costs
• Specialized stem cell extraction capability positions company among select few nationwide facilities
• Ahead of projected timeline for clinic opening
• Establishes scalable model for future nationwide expansion

Negative

• Initial capital investment required for clinic lease and operations
• Revenue generation dependent on successful patient acquisition starting January 2025

News Market Reaction

+92.31%

1 alert

+92.31% News Effect

On the day this news was published, ADIA gained 92.31%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WINTER PARK, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. proudly announces the signed lease for their state-of-the-art clinic, set to open in the distinguished Winter Park Medical Center. This clinic not only marks Adia Nutrition's inaugural venture into physical medical facilities but also introduces a rare stem cell extraction department, a feature shared by only a handful of clinics nationwide.

The newly leased clinic comes fully built-out and recently remodeled, providing an ideal space for Adia Nutrition's medical division to commence operations. This facility will feature a private stem cell extraction room as well as private IV rooms to ensure the highest level of privacy and comfort of patients. This setup is perfectly tailored for the administration of Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for patients with Multiple Sclerosis (MS), ensuring comprehensive and cutting-edge care.

Securing this prime location has propelled Adia Nutrition well ahead of its projected timeline. With this lease in place, the company is now on track to have the clinic operational by the end of the year, aiming to start accepting patients on January 1st, 2025.

Adia Nutrition's strategic move to open this clinic underscores the company's dedication to pioneering treatments for chronic conditions, leveraging state-of-the-art facilities to bring hope and healing closer to those in need.

"Our new medical clinic will not only define the standard of care we aim to deliver to patients but will also serve as our clinic model for all future locations,” said Larry Powalisz, CEO of Adia Nutrition. “This will significantly accelerate the development and rollout of future clinics nationwide.”

For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.

About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.

Website: www.adianutrition.com
Website: www.adia-med.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition

Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/ceadba64-5879-4e25-b9da-60004bfda9e2

https://www.globenewswire.com/NewsRoom/AttachmentNg/72d2897e-9ad7-428d-a12b-6250d4aef017

FAQ

When will Adia Nutrition (ADIA) open its first medical clinic in Winter Park?

Adia Nutrition's first clinic is scheduled to begin accepting patients on January 1st, 2025, with operations starting by the end of 2024.

What specialized treatments will Adia Nutrition's Winter Park clinic offer?

The clinic will offer Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Multiple Sclerosis patients, featuring rare stem cell extraction capabilities.

Where is Adia Nutrition's first medical clinic located?

The clinic is located in the Winter Park Medical Center in Winter Park, Florida.

What unique features does Adia Nutrition's new clinic include?

The clinic includes a private stem cell extraction room and private IV rooms, with fully built-out and recently remodeled facilities.